Works by Österborg, Anders

Results: 91

Ibrutinib versus previous standard of care: an adjusted comparison in patients with relapsed/refractory chronic lymphocytic leukaemia.

Published in:

2017

By:

Hansson, Lotta;
Asklid, Anna;
Diels, Joris;
Eketorp-Sylvan, Sandra;
Repits, Johanna;
Søltoft, Frans;
Jäger, Ulrich;
Österborg, Anders;
Søltoft, Frans;
Jäger, Ulrich;
Österborg, Anders

Publication type:

journal article

Phase I/II randomised study of a novel erythropoiesis-stimulating agent (AMG 114) for the treatment of anaemia with concomitant chemotherapy in patients with non-myeloid malignancies.

Published in:

2011

By:

Boer, Richard;
Clemens, Michael;
Renczes, Gabor;
Kotasek, Dusan;
Prausova, Jana;
Marschner, Norbert;
Hedenus, Michael;
Doshi, Sameer;
Hendricks, Lisa;
Österborg, Anders;
de Boer, Richard;
Österborg, Anders C

Publication type:

journal article

Differential expression of viral agents in lymphoma tissues of patients with ABC diffuse large B-cell lymphoma from high and low endemic infectious disease regions.

Published in:

Oncology Letters, 2016, v. 12, n. 4, p. 2782, doi. 10.3892/ol.2016.5012

By:

HÖGFELDT, THERESE;
JAING, CRYSTAL;
LOUGHLIN, KEVIN Mc;
THISSEN, JAMES;
GARDNER, SHEA;
BAHNASSY, ABEER A.;
GHARIZADEH, BABACK;
LUNDAHL, JOACHIM;
ÖSTERBORG, ANDERS;
PORWIT, ANNA;
ZEKRI, ABDEL-RAHMAN N.;
KHALED, HUSSEIN M.;
MELLSTEDT, HÅKAN;
MOSHFEGH, ALI

Publication type:

Article

Response to interferon therapy in patients with multiple myeloma correlates with expression of the Bcl-2 oncoprotein.

Published in:

International Journal of Cancer, 1995, v. 63, n. 2, p. 190, doi. 10.1002/ijc.2910630207

By:

Sangfelt, Olle;
Österborg, Anders;
Grandér, Dan;
Anderbring, Elisabet;
Öst, Åke;
Mellstedt, Håkan;
Einhorn, Stefan

Publication type:

Article

A receptor tyrosine kinase ROR1 inhibitor (KAN0439834) induced significant apoptosis of pancreatic cells which was enhanced by erlotinib and ibrutinib.

Published in:

PLoS ONE, 2018, v. 13, n. 5, p. 1, doi. 10.1371/journal.pone.0198038

By:

Daneshmanesh, Amir Hossein;
Hojjat-Farsangi, Mohammad;
Ghaderi, Amineh;
Moshfegh, Ali;
Hansson, Lotta;
Schultz, Johan;
Vågberg, Jan;
Byström, Styrbjörn;
Olsson, Elisabeth;
Olin, Thomas;
Österborg, Anders;
Mellstedt, Håkan

Publication type:

Article

Autologous T cells expressing the oncogenic transcription factor KLF6-SV1 prevent apoptosis of chronic lymphocytic leukemia cells.

Published in:

PLoS ONE, 2018, v. 13, n. 2, p. 1, doi. 10.1371/journal.pone.0192839

By:

Kokhaei, Parviz;
Hojjat-Farsangi, Mohammad;
Mozaffari, Fariba;
Moshfegh, Ali;
Pak, Fatemeh;
Rashidy-Pour, Ali;
Palma, Marzia;
Hansson, Lotta;
Österborg, Anders;
Mellstedt, Håkan

Publication type:

Article

Targeting Tumor Microenvironment Interactions in Chronic Lymphocytic Leukemia Using Leukotriene Inhibitors.

Published in:

International Journal of Molecular Sciences, 2025, v. 26, n. 5, p. 2209, doi. 10.3390/ijms26052209

By:

Sadeghi, Laia;
Merrien, Magali;
Björkholm, Magnus;
Österborg, Anders;
Sander, Birgitta;
Claesson, Hans-Erik;
Wright, Anthony P. H.

Publication type:

Article

Phase I-II study of lenalidomide and alemtuzumab in refractory chronic lymphocytic leukemia (CLL): effects on T cells and immune checkpoints.

Published in:

Cancer Immunology, Immunotherapy, 2017, v. 66, n. 1, p. 91, doi. 10.1007/s00262-016-1922-6

By:

Winqvist, Maria;
Mozaffari, Fariba;
Palma, Marzia;
Eketorp Sylvan, Sandra;
Hansson, Lotta;
Mellstedt, Håkan;
Österborg, Anders;
Lundin, Jeanette

Publication type:

Article

T cells from indolent CLL patients prevent apoptosis of leukemic B cells in vitro and have altered gene expression profile.

Published in:

Cancer Immunology, Immunotherapy, 2013, v. 62, n. 1, p. 51, doi. 10.1007/s00262-012-1300-y

By:

Kiaii, Shahryar;
Kokhaei, Parviz;
Mozaffari, Fariba;
Rossmann, Eva;
Pak, Fatemeh;
Moshfegh, Ali;
Palma, Marzia;
Hansson, Lotta;
Mashayekhi, Kaveh;
Hojjat-Farsangi, Mohammad;
Österborg, Anders;
Choudhury, Aniruddha;
Mellstedt, Håkan

Publication type:

Article

Vaccination with dendritic cells loaded with tumor apoptotic bodies (Apo-DC) in patients with chronic lymphocytic leukemia: effects of various adjuvants and definition of immune response criteria.

Published in:

Cancer Immunology, Immunotherapy, 2012, v. 61, n. 6, p. 865, doi. 10.1007/s00262-011-1149-5

By:

Palma, Marzia;
Hansson, Lotta;
Choudhury, Aniruddha;
Näsman-Glaser, Barbro;
Eriksson, Ingrid;
Adamson, Lars;
Rossmann, Eva;
Widén, Karin;
Horváth, Rudolf;
Kokhaei, Parviz;
Vertuani, Simona;
Mellstedt, Håkan;
Österborg, Anders

Publication type:

Article

First International Meeting of the Thematic Centre for Immune Modulatory Therapies for Autoimmunity and Cancer (IMTAC) 13-14 June 2011, Ljusterö, Sweden.

Published in:

2012

By:

Choudhury, Aniruddha;
Höglund, Petter;
Kiessling, Rolf;
Kärre, Klas;
Lundqvist, Andreas;
Malmberg, Kalle;
Mellstedt, Håkan;
Scheynius, Annika;
Winqvist, Ola;
Österborg, Anders

Publication type:

Report

Systemic immune effects of adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide and/or radiotherapy in breast cancer: a longitudinal study.

Published in:

Cancer Immunology, Immunotherapy, 2009, v. 58, n. 1, p. 111, doi. 10.1007/s00262-008-0530-5

By:

Mozaffari, Fariba;
Lindemalm, Christina;
Choudhury, Aniruddha;
Granstam-Björneklett, Helena;
Lekander, Mats;
Nilsson, Bo;
Ojutkangas, Marja-Leena;
Österborg, Anders;
Bergkvist, Leif;
Mellstedt, Håkan

Publication type:

Article

The cost-effectiveness of treatment with erythropoietin compared to red blood cell transfusions for patients with chemotherapy induced anaemia: A Markov model.

Published in:

Acta Oncologica, 2008, v. 47, n. 6, p. 1009, doi. 10.1080/02841860701744498

By:

Borg, Sixten;
Glenngård, Anna H.;
Österborg, Anders;
Persson, Ulf

Publication type:

Article

Idiotype Immunity (Natural and Vaccine-induced) in Early Stage Multiple Myeloma.

Published in:

Acta Oncologica, 2000, v. 39, n. 7, p. 797, doi. 10.1080/028418600750063523

By:

Österborg, Anders;
Henriksson, Lotta;
Mellstedt, Håkan

Publication type:

Article

The Tyrosine Kinase Receptor ROR1 Is Constitutively Phosphorylated in Chronic Lymphocytic Leukemia (CLL) Cells.

Published in:

PLoS ONE, 2013, v. 8, n. 10, p. 1, doi. 10.1371/journal.pone.0078339

By:

Hojjat-Farsangi, Mohammad;
Khan, Abdul Salam;
Daneshmanesh, Amir Hossein;
Moshfegh, Ali;
Sandin, Åsa;
Mansouri, Ladan;
Palma, Marzia;
Lundin, Jeanette;
Österborg, Anders;
Mellstedt, Håkan

Publication type:

Article

A Proline/Arginine-Rich End Leucine-Rich Repeat Protein (PRELP) Variant Is Uniquely Expressed in Chronic Lymphocytic Leukemia Cells.

Published in:

PLoS ONE, 2013, v. 8, n. 6, p. 1, doi. 10.1371/journal.pone.0067601

By:

Mikaelsson, Eva;
Österborg, Anders;
Jeddi-Tehrani, Mahmood;
Kokhaei, Parviz;
Ostadkarampour, Mahyar;
Hadavi, Reza;
Gholamin, Mehran;
Akhondi, Mehdi;
Shokri, Fazel;
Rabbani, Hodjattallah;
Mellstedt, Håkan

Publication type:

Article

Polycomb Target Genes Are Silenced in Multiple Myeloma.

Published in:

PLoS ONE, 2010, v. 5, n. 7, p. 1, doi. 10.1371/journal.pone.0011483

By:

Kalushkova, Antonia;
Fryknäs, Mårten;
Lemaire, Miguel;
Fristedt, Charlotte;
Agarwal, Prasoon;
Eriksson, Maria;
Deleu, Sarah;
Atadja, Peter;
Österborg, Anders;
Nilsson, Kenneth;
Vanderkerken, Karin;
Öberg, Fredrik;
Jernberg-Wiklund, Helena

Publication type:

Article

Do reduced numbers of plasmacytoid dendritic cells contribute to the aggressive clinical course of COVID‐19 in chronic lymphocytic leukaemia?

Published in:

Scandinavian Journal of Immunology, 2022, v. 95, n. 4, p. 1, doi. 10.1111/sji.13153

By:

Smith, Carl Inge Edvard;
Zain, Rula;
Österborg, Anders;
Palma, Marzia;
Buggert, Marcus;
Bergman, Peter;
Bryceson, Yenan

Publication type:

Article

Temporary cessation of ibrutinib results in reduced grade 3‐4 infections and durable remissions—Interim analysis of an on‐off‐repeat Phase 1b/2 study in patients with chronic lymphocytic leukemia.

Published in:

EJHaem, 2021, v. 2, n. 3, p. 525, doi. 10.1002/jha2.261

By:

Lundin, Jeanette;
Mulder, Tom A.;
Kättström, Magdalena;
Wästerlid, Tove;
Uddevik, Anders;
Mellstedt, Håkan;
Heimersson, Kia;
Hansson, Lotta;
Palma, Marzia;
Österborg, Anders

Publication type:

Article

A ROR1 small molecule inhibitor (KAN0441571C) induced significant apoptosis of ibrutinib‐resistant ROR1<sup>+</sup> CLL cells.

Published in:

EJHaem, 2021, v. 2, n. 3, p. 498, doi. 10.1002/jha2.232

By:

Ghaderi, Amineh;
Okhovat, Mohammad‐Ali;
Wikanthi, Layung Sekar Sih;
Svensson, Ann;
Palma, Marzia;
Schultz, Johan;
Olin, Thomas;
Österborg, Anders;
Mellstedt, Håkan;
Hojjat‐Farsangi, Mohammad

Publication type:

Article

Dendritic cell regulation of NK-cell responses involves lymphotoxin-α, IL-12, and TGF-β.

Published in:

European Journal of Immunology, 2015, v. 45, n. 6, p. 1783, doi. 10.1002/eji.201444885

By:

Sarhan, Dhifaf;
Palma, Marzia;
Mao, Yumeng;
Adamson, Lars;
Kiessling, Rolf;
Mellstedt, Håkan;
Österborg, Anders;
Lundqvist, Andreas

Publication type:

Article

Additive effects of booster mRNA vaccination and SARS-CoV-2 Omicron infection on T cell immunity across immunocompromised states.

Published in:

Science Translational Medicine, 2023, v. 15, n. 704, p. 1, doi. 10.1126/scitranslmed.adg9452

By:

Müller, Thomas R.;
Sekine, Takuya;
Trubach, Darya;
Niessl, Julia;
Chen, Puran;
Bergman, Peter;
Blennow, Ola;
Hansson, Lotta;
Mielke, Stephan;
Nowak, Piotr;
Vesterbacka, Jan;
Akber, Mira;
Olofsson, Anna;
Amaya Hernandez, Susana Patricia;
Gao, Yu;
Cai, Curtis;
Söderdahl, Gunnar;
Smith, C. I. Edvard;
Österborg, Anders;
Loré, Karin

Publication type:

Article

Ofatumumab: A New CD20 Monoclonal Antibody Therapy for B-Cell Chronic Lymphocytic Leukemia.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2010, v. 10, n. 5, p. 361, doi. 10.3816/CLML.2010.n.069

By:

O'Brien, Susan;
Österborg, Anders

Publication type:

Article

Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapy.

Published in:

Cancer (0008543X), 2003, v. 97, n. 12, p. 3125

By:

Anders Österborg;
Yvonne Brandberg

Publication type:

Article

Ofatumumab, a Novel CD20 Monoclonal Antibody, Is Active in Patients With Fludarabine- and Alemtuzumab-Refractory or Bulky Fludarabine-Refractory Chronic Lymphocytic Leukemia Irrespective of Prior Rituximab.

Published in:

Clinical Lymphoma & Myeloma, 2009, v. 9, n. 6, p. E36, doi. 10.3816/CLM.2009.n.098

By:

Wierda, William;
Kipps, Thomas;
Mayer, Jiří;
Stilgenbauer, Stephan;
Williams, Cathy D.;
Hellmann, Andrzej;
Robak, Tadeusz;
Furman, Richard R.;
Hillmen, Peter;
Trneny, Marek;
Dyer, Martin J.S.;
Padmanabhan, Swami;
Piotrowska, Magdalena;
Kozak, Tomas;
Chan, Geoffrey;
Davis, Randy;
Losic, Nedjad;
Wilms, Joris;
Russell, Charlotte;
Österborg, Anders

Publication type:

Article

MAIT cell compartment characteristics are associated with the immune response magnitude to the BNT162b2 mRNA anti-SARS-CoV-2 vaccine.

Published in:

Molecular Medicine, 2022, v. 28, n. 1, p. 1, doi. 10.1186/s10020-022-00484-7

By:

Boulouis, Caroline;
Kammann, Tobias;
Cuapio, Angelica;
Parrot, Tiphaine;
Gao, Yu;
Mouchtaridi, Elli;
Wullimann, David;
Lange, Joshua;
Chen, Puran;
Akber, Mira;
Rivera Ballesteros, Olga;
Muvva, Jagadeeswara Rao;
COVAXID study group;
Sällberg Chen, Margaret;
Healy, Katie;
Sobkowiak, Michal;
Söderdahl, Gunnar;
Blennow, Ola;
Österborg, Anders;
Mielke, Stephan

Publication type:

Article

Alemtuzumab: A Viewpoint by Anders Österborg.

Published in:

Drugs, 2003, v. 63, n. 12, p. 1245

By:

Österborg, Anders

Publication type:

Article

Ror1, a cell surface receptor tyrosine kinase is expressed in chronic lymphocytic leukemia and may serve as a putative target for therapy.

Published in:

International Journal of Cancer, 2008, v. 123, n. 5, p. 1190, doi. 10.1002/ijc.23587

By:

DaneshManesh, Amir H.;
Mikaelsson, Eva;
Jeddi-Tehrani, Mahmood;
Bayat, Ali Ahmad;
Ghods, Roya;
Ostadkarampour, Mahyar;
Akhondi, Mehdi;
Lagercrantz, Svetlana;
Larsson, Catharina;
Österborg, Anders;
Shokri, Fazel;
Mellstedt, Håkan;
Rabbani, Hodjattallah

Publication type:

Article

Biologic Response Modifiers in the Treatment of Gastrointestinal Malignancies.

Published in:

Scandinavian Journal of Gastroenterology, 1989, v. 24, n. 3, p. 257, doi. 10.3109/00365528909093044

By:

Mellstedt, Håkan;
Frödin, Jan-Erik;
Lindemalm, Christina;
Masucci, Giuseppe;
Merk, Karl;
Pettersson, Dagny;
Ragnhammar, Peter;
Steinitz, Michael;
Wedelin, Christina;
Wersåll, Peter;
Österborg, Anders

Publication type:

Article

Population pharmacokinetics of ofatumumab in patients with chronic lymphocytic leukemia, follicular lymphoma, and rheumatoid arthritis.

Published in:

Journal of Clinical Pharmacology, 2014, v. 54, n. 7, p. 818, doi. 10.1002/jcph.268

By:

Struemper, Herbert;
Sale, Mark;
Patel, Bela R.;
Østergaard, Mikkel;
Österborg, Anders;
Wierda, William G.;
Hagenbeek, Anton;
Coiffier, Bertrand;
Jewell, Roxanne C.

Publication type:

Article

Alemtuzumab to treat refractory autoimmune hemolytic anemia or thrombocytopenia in chronic lymphocytic leukemia.

Published in:

Current Hematologic Malignancy Reports, 2009, v. 4, n. 1, p. 47, doi. 10.1007/s11899-009-0007-4

By:

Österborg, Anders;
Karlsson, Claes;
Lundin, Jeanette

Publication type:

Article

Risk of COVID-19 hospitalisation by HIV-status and SARS-CoV-2 vaccination status during pre- and post-Omicron era in a national register-based cohort study in Sweden.

Published in:

Infectious Diseases, 2025, v. 57, n. 2, p. 178, doi. 10.1080/23744235.2024.2405582

By:

Killander Möller, Isabela;
Hedberg, Pontus;
Wagner, Philippe;
Lindahl, Hannes;
Nyström, Sofia;
Blixt, Lisa;
Eketorp Sylvan, Sandra;
Nilsdotter-Augustinsson, Åsa;
Österborg, Anders;
Fredrikson, Mats;
Hansson, Lotta;
Kahn, Fredrik;
Sparén, Pär;
Gisslén, Magnus;
Nauclér, Pontus;
Bergman, Peter;
Aleman, Soo;
Carlander, Christina

Publication type:

Article

ROR1 is Expressed in Diffuse Large B-Cell Lymphoma (DLBCL) and a Small Molecule Inhibitor of ROR1 (KAN0441571C) Induced Apoptosis of Lymphoma Cells.

Published in:

Biomedicines, 2020, v. 8, n. 6, p. 170, doi. 10.3390/biomedicines8060170

By:

Ghaderi, Amineh;
Daneshmanesh, Amir Hossein;
Moshfegh, Ali;
Kokhaei, Parviz;
Vågberg, Jan;
Schultz, Johan;
Olin, Thomas;
Harrysson, Sara;
Smedby, Karin E;
Drakos, Elias;
Rassidakis, Georgios Z.;
Österborg, Anders;
Mellstedt, Håkan;
Hojjat-Farsangi, Mohammad

Publication type:

Article

A Small Molecule Antagonist of CX3CR1 (KAND567) Inhibited the Tumor Growth-Promoting Effect of Monocytes in Chronic Lymphocytic Leukemia (CLL).

Published in:

Cancers, 2024, v. 16, n. 22, p. 3821, doi. 10.3390/cancers16223821

By:

Zhong, Wen;
Kokhaei, Parviz;
Mulder, Tom A.;
Ghaderi, Amineh;
Moshfegh, Ali;
Lundin, Jeanette;
Palma, Marzia;
Schultz, Johan;
Olin, Thomas;
Österborg, Anders;
Mellstedt, Håkan;
Hojjat-Farsangi, Mohammad

Publication type:

Article

Sting Is Commonly and Differentially Expressed in T- and Nk-Cell but Not B-Cell Non-Hodgkin Lymphomas.

Published in:

Cancers, 2022, v. 14, n. 5, p. 1186, doi. 10.3390/cancers14051186

By:

Xagoraris, Ioanna;
Farrajota Neves da Silva, Pedro;
Kokaraki, Georgia;
Stathopoulou, Konstantina;
Wahlin, Björn;
Österborg, Anders;
Herold, Nikolas;
Ng, Siok-Bian;
Medeiros, L. Jeffrey;
Drakos, Elias;
Sander, Birgitta;
Rassidakis, George Z.

Publication type:

Article

Targeting the Immune Microenvironment in Lymphomas of B-Cell Origin: From Biology to Clinical Application.

Published in:

Cancers, 2019, v. 11, n. 7, p. 915, doi. 10.3390/cancers11070915

By:

Mulder, Tom A.;
Wahlin, Björn E.;
Österborg, Anders;
Palma, Marzia

Publication type:

Article

Long-term effects of idiotype vaccination on the specific T-cell response in peripheral blood and bone marrow of multiple myeloma patients.

Published in:

European Journal of Haematology, 2007, v. 79, n. 5, p. 371, doi. 10.1111/j.1600-0609.2007.00962.x

By:

Abdalla, Amir Osman;
Hansson, Lotta;
Eriksson,3, Ingrid;
Näsman-Glaser, Barbro;
Mellstedt, Håkan;
Österborg, Anders

Publication type:

Article

Intracellular T cell cytokines in patients with B cell chronic lymphocytic leukaemia (B-CLL).

Published in:

European Journal of Haematology, 2002, v. 68, n. 5, p. 299, doi. 10.1034/j.1600-0609.2002.01612.x

By:

Rossmann, Eva D.;
Lewin, Nongnit;
Jeddi-Tehrani, Mahmood;
Österborg, Anders;
Mellstedt, Håkan

Publication type:

Article

The influence of interferon-α on the pharmacokinetics of cyclophosphamide and its 4-hydroxy metabolite in patients with multiple myeloma.

Published in:

European Journal of Haematology, 1999, v. 63, n. 3, p. 163, doi. 10.1111/j.1600-0609.1999.tb01764.x

By:

Hassan, Moustapha;
Nilsson, Christina;
Olsson, Hanna;
Lundin, Jeanette;
Österborg, Anders

Publication type:

Article

Blood clonal B cell excess at diagnosis in multiple myeloma: Relation to prognosis.

Published in:

European Journal of Haematology, 1987, v. 38, n. 2, p. 173, doi. 10.1111/j.1600-0609.1987.tb01158.x

By:

Österborg, Anders;
Nilsson, Bo;
Bjorkholm, Magnus;
Holm, Goran;
Johansson, Bo;
Lindemalm, Christina;
Petterson, Dagny;
Åhre, Anders;
Mellstedt, Håkan

Publication type:

Article

RETRACTED ARTICLE: Survival of MM cells is dependent on Notch signaling.

Published in:

2011

By:

Liu, Chen;
Kang, Jianmin;
Qiao, Zhenhua;
Yang, Linhua;
Wiernik, Peter H;
Österborg, Anders

Publication type:

corrected article

Erythropoietin therapy and cancer related anaemia: updated Swedish recommendations.

Published in:

Medical Oncology, 2007, v. 24, n. 3, p. 267, doi. 10.1007/s12032-007-0037-5

By:

Jane Ahlqvist-Rastad;
Maria Albertsson;
Jonas Bergh;
Gunnar Birgegård;
Peter Johansson;
Bertil Jonsson;
Elisabeth Kjellen;
Sven Påhlman;
Björn Zackrisson;
Anders Österborg

Publication type:

Article

Risk‐adapted bendamustine + rituximab is a tolerable treatment alternative for elderly patients with chronic lymphocytic leukaemia: a regional real‐world report on 141 consecutive Swedish patients.

Published in:

British Journal of Haematology, 2020, v. 191, n. 3, p. 426, doi. 10.1111/bjh.17032

By:

Mattsson, Agnes;
Sylvan, Sandra E.;
Asklid, Anna;
Wiggh, Joel;
Winqvist, Maria;
Lundin, Jeanette;
Mansouri, Larry;
Rosenquist, Richard;
Johansson, Hemming;
Österborg, Anders;
Hansson, Lotta

Publication type:

Article

Five‐year survival follow‐up of a phase III randomised trial comparing ofatumumab versus physicians' choice for bulky fludarabine‐refractory chronic lymphocytic leukaemia: a short report.

Published in:

British Journal of Haematology, 2020, v. 189, n. 4, p. 689, doi. 10.1111/bjh.16429

By:

Miklos, Udvardy;
Strugov, Vladimir;
Lewerin, Catharina;
Grosicki, Sebastian;
Mazur, Grzegorz;
Steurer, Michael;
Montillo, Marco;
Kryachok, Irina;
Middeke, Jan M.;
Rekhtman, Grygoriy;
Stefanelli, Tommaso;
Vincent, Ghislaine;
Govindaraju, Sameera;
Österborg, Anders

Publication type:

Article

HAX‐1 overexpression in multiple myeloma is associated with poor survival.

Published in:

British Journal of Haematology, 2019, v. 185, n. 1, p. 179, doi. 10.1111/bjh.15430

By:

Feng, Xiaoli;
Kwiecinska, Anna;
Rossmann, Eva;
Bottai, Matteo;
Ishikawa, Taichi;
Patarroyo, Manuel;
Österborg, Anders;
Porwit, Anna;
Zheng, Chengyun;
Fadeel, Bengt

Publication type:

Article

Ibrutinib induces rapid down‐regulation of inflammatory markers and altered transcription of chronic lymphocytic leukaemia‐related genes in blood and lymph nodes.

Published in:

British Journal of Haematology, 2018, v. 183, n. 2, p. 212, doi. 10.1111/bjh.15516

By:

Palma, Marzia;
Krstic, Aleksandra;
Peña Perez, Lucia;
Berglöf, Anna;
Meinke, Stephan;
Wang, Qing;
Blomberg, K. Emelie M.;
Kamali‐Moghaddam, Masood;
Shen, Qiujin;
Jaremko, Georg;
Lundin, Jeanette;
De Paepe, Ayla;
Höglund, Petter;
Kimby, Eva;
Österborg, Anders;
Månsson, Robert;
Smith, C. I. Edvard

Publication type:

Article

Dual targeting of Bruton tyrosine kinase and CD52 induces minimal residual disease‐negativity in the bone marrow of poor‐prognosis chronic lymphocytic leukaemia patients but is associated with opportunistic infections – Results from a phase I study

Published in:

British Journal of Haematology, 2018, v. 182, n. 4, p. 590, doi. 10.1111/bjh.14836

By:

Winqvist, Maria;
Palma, Marzia;
Heimersson, Kia;
Mellstedt, Håkan;
Österborg, Anders;
Lundin, Jeanette

Publication type:

Article

Ofatumumab retreatment and maintenance in fludarabine-refractory chronic lymphocytic leukaemia patients.

Published in:

British Journal of Haematology, 2015, v. 170, n. 1, p. 40, doi. 10.1111/bjh.13380

By:

Österborg, Anders;
Wierda, William G.;
Mayer, Jiří;
Hess, Georg;
Hillmen, Peter;
Schetelig, Johannes;
Schuh, Anna;
Smolej, Lukáš;
Beck, Christian;
Dreyfus, Brigitte;
Hellman, Andrzej;
Kozlowski, Piotr;
Pfreundschuh, Michael;
Rizzi, Rita;
Spacek, Martin;
Phillips, Jennifer L.;
Gupta, Ira V.;
Williams, Vanessa;
Jewell, Roxanne C.;
Nebot, Noelia

Publication type:

Article

The PI3K/AKT/mTOR pathway is involved in direct apoptosis of CLL cells induced by ROR1 monoclonal antibodies.

Published in:

British Journal of Haematology, 2015, v. 169, n. 3, p. 455, doi. 10.1111/bjh.13228

By:

Daneshmanesh, Amir Hossein;
Hojjat‐Farsangi, Mohammad;
Moshfegh, Ali;
Khan, Abdul Salam;
Mikaelsson, Eva;
Österborg, Anders;
Mellstedt, Håkan

Publication type:

Article

Phase I study of lenalidomide and alemtuzumab in refractory chronic lymphocytic leukaemia: maintaining immune functions during therapy-induced immunosuppression.

Published in:

British Journal of Haematology, 2012, v. 159, n. 5, p. 0, doi. 10.1111/bjh.12077

By:

Sylvan, Sandra Eketorp;
Rossmann, Eva;
Mozaffari, Fariba;
Porwit, Anna;
Norin, Stefan;
Karlsson, Claes;
Hansson, Lotta;
Lundin, Jeanette;
Österborg, Anders

Publication type:

Article